Green Tea Extract for Weight Loss: A Review of the Evidence
Last reviewed: 21 de Março de 2026 às 11:53
Green tea extract (GTE) is one of the most extensively studied natural compounds for weight management. The primary bioactive catechin, epigallocatechin gallate (EGCG), has been investigated in over 50 randomized controlled trials for its effects on body weight, body fat, and metabolic parameters. A 2012 Cochrane review analyzed 14 trials and found that green tea preparations produced a small but statistically significant reduction in body weight (approximately 0.95 kg) compared to placebo. More recent meta-analyses have produced similar findings, generally showing modest effects that vary by population, dosage, and study duration.
The proposed mechanisms through which GTE may influence body composition include inhibition of catechol-O-methyltransferase (COMT), which degrades norepinephrine, thereby prolonging sympathetic nervous system stimulation and thermogenesis. EGCG may also modulate AMPK (AMP-activated protein kinase), a cellular energy sensor involved in fat oxidation. In laboratory studies, green tea catechins have shown effects on adipocyte differentiation and lipid metabolism. However, translating these mechanistic findings from cell culture and animal models to clinically meaningful human outcomes remains a significant challenge in nutrition research.
Study quality and design significantly influence the reported outcomes. Trials conducted in Asian populations, particularly in Japan and China, have generally shown larger effects than those in Western populations, which may reflect genetic differences in COMT activity or habitual caffeine consumption. Many studies used green tea extract combined with caffeine, making it difficult to isolate the independent effect of catechins. The synergistic interaction between EGCG and caffeine appears to enhance thermogenic effects beyond what either compound produces alone. Dosages in positive trials typically ranged from 270 to 800 mg of EGCG daily, though optimal dosing remains uncertain.
Important limitations of the current evidence base must be acknowledged. Most trials were relatively short (8-12 weeks), and longer-term effects on weight maintenance are less studied. Publication bias may inflate the apparent effectiveness, as studies showing null results are less likely to be published. Individual response variation is substantial, and some people may experience no measurable benefit. Hepatotoxicity has been reported in rare cases with high-dose green tea extract supplements, particularly when taken on an empty stomach, leading some regulatory agencies to recommend upper limits on EGCG intake (typically 800 mg per day from supplements). Anyone considering GTE supplementation should discuss it with their healthcare provider, particularly those with liver conditions or taking medications metabolized by the liver.
The proposed mechanisms through which GTE may influence body composition include inhibition of catechol-O-methyltransferase (COMT), which degrades norepinephrine, thereby prolonging sympathetic nervous system stimulation and thermogenesis. EGCG may also modulate AMPK (AMP-activated protein kinase), a cellular energy sensor involved in fat oxidation. In laboratory studies, green tea catechins have shown effects on adipocyte differentiation and lipid metabolism. However, translating these mechanistic findings from cell culture and animal models to clinically meaningful human outcomes remains a significant challenge in nutrition research.
Study quality and design significantly influence the reported outcomes. Trials conducted in Asian populations, particularly in Japan and China, have generally shown larger effects than those in Western populations, which may reflect genetic differences in COMT activity or habitual caffeine consumption. Many studies used green tea extract combined with caffeine, making it difficult to isolate the independent effect of catechins. The synergistic interaction between EGCG and caffeine appears to enhance thermogenic effects beyond what either compound produces alone. Dosages in positive trials typically ranged from 270 to 800 mg of EGCG daily, though optimal dosing remains uncertain.
Important limitations of the current evidence base must be acknowledged. Most trials were relatively short (8-12 weeks), and longer-term effects on weight maintenance are less studied. Publication bias may inflate the apparent effectiveness, as studies showing null results are less likely to be published. Individual response variation is substantial, and some people may experience no measurable benefit. Hepatotoxicity has been reported in rare cases with high-dose green tea extract supplements, particularly when taken on an empty stomach, leading some regulatory agencies to recommend upper limits on EGCG intake (typically 800 mg per day from supplements). Anyone considering GTE supplementation should discuss it with their healthcare provider, particularly those with liver conditions or taking medications metabolized by the liver.